Literature DB >> 18591884

Growth hormone isoforms release in response to physiological and pharmacological stimuli.

S Pagani1, M Cappa, C Meazza, G Ubertini, P Travaglino, E Bozzola, M Bozzola.   

Abstract

Ten healthy subjects used to performing regular physical activity and eight subjects affected by idiopathic isolated GH deficiency (GHD) were enrolled; 22- and 20-kDa GH secretion and its biological activity were evaluated in response to pharmacological stimuli such as arginine, L-dopa or glucagon in GHD children, while the hormonal response to exercise was studied according to Bruce protocol in healthy subjects. We found a significant increase in 22- and 20-kDa GH level in healthy subjects after monitored physical exercise (MPE; basal 0.28+/-0.12 vs 7.37+/-2.08 ng/ml and basal 0.076+/-0.04 vs 0.18+/-0.05 ng/ml, respectively). Furthermore, the 22-kDa/20-kDa ratio significantly increased in children who had undergone MPE and the GH bioactivity basal mean value also increased significantly after exercise (basal 2.86+/-0.76 vs 7.64+/-1.9 ng/ml). The mean value of 22-kDa GH in GHD patients increased significantly following GH pharmacological stimulation (2.78+/-0.63 ng/ml) when compared with mean basal (0.20+/-0.11 ng/ml) value. In the GHD group the basal concentration of 20-kDa GH significantly increased following GH pharmacological stimulation (0.34+/-0.11 vs 0.72+/-0.2 ng/ml); the 22-kDa/20-kDa ratio significantly increased too. Likewise, GH bioactivity in children with GHD increased significantly after pharmacological stimulation test (basal 2.53+/-0.56 vs 7.33+/-1.26 ng/ml). Both GH isoform concentrations and their biological activity are significantly increased in healthy subjects after submaximal exercise protocol and in GHD children after pharmacological stimuli.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18591884     DOI: 10.1007/BF03346401

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  24 in total

1.  Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society.

Authors: 
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

2.  Construction of a specific and sensitive sandwich enzyme immunoassay for 20 kDa human growth hormone.

Authors:  Y Hashimoto; I Ikeda; M Ikeda; Y Takahashi; M Hosaka; H Uchida; N Kono; H Fukui; T Makino; M Honjo
Journal:  J Immunol Methods       Date:  1998-12-01       Impact factor: 2.303

3.  Molecular forms of human growth hormone secreted in vivo: nonspecificity of secretory stimuli.

Authors:  G Baumann; M W Stolar
Journal:  J Clin Endocrinol Metab       Date:  1986-04       Impact factor: 5.958

4.  A serum-free medium for culturing lactogen dependent and autonomous NB2 node lymphoma cells.

Authors:  A Walker; F Croze; H G Friesen
Journal:  Endocrinology       Date:  1987-06       Impact factor: 4.736

5.  Secretion of authentic 20-kDa human growth hormone (20K hGH) in Escherichia coli and properties of the purified product.

Authors:  H Uchida; N Naito; N Asada; M Wada; M Ikeda; H Kobayashi; M Asanagi; K Mori; Y Fujita; K Konda; N Kusuhara; T Kamioka; K Nakashima; M Honjo
Journal:  J Biotechnol       Date:  1997-06-13       Impact factor: 3.307

6.  Impact of acute exercise intensity on pulsatile growth hormone release in men.

Authors:  C J Pritzlaff; L Wideman; J Y Weltman; R D Abbott; M E Gutgesell; M L Hartman; J D Veldhuis; A Weltman
Journal:  J Appl Physiol (1985)       Date:  1999-08

7.  Increased proportion of circulating non-22-kilodalton growth hormone isoforms in short children: a possible mechanism for growth failure.

Authors:  C L Boguszewski; C Jansson; M C Boguszewski; S Rosberg; B Carlsson; K Albertsson-Wikland; L M Carlsson
Journal:  J Clin Endocrinol Metab       Date:  1997-09       Impact factor: 5.958

Review 8.  Growth hormone responses to sub-maximal and sprint exercise.

Authors:  Keith Stokes
Journal:  Growth Horm IGF Res       Date:  2003-10       Impact factor: 2.372

9.  A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum.

Authors:  T Tanaka; R P Shiu; P W Gout; C T Beer; R L Noble; H G Friesen
Journal:  J Clin Endocrinol Metab       Date:  1980-11       Impact factor: 5.958

10.  Growth hormone: important role in muscular exercise in adults.

Authors:  W M Hunter; C C Fonseka; R Passmore
Journal:  Science       Date:  1965-11-19       Impact factor: 47.728

View more
  1 in total

Review 1.  Growth hormone: isoforms, clinical aspects and assays interference.

Authors:  Júnia Ribeiro de Oliveira Longo Schweizer; Antônio Ribeiro-Oliveira; Martin Bidlingmaier
Journal:  Clin Diabetes Endocrinol       Date:  2018-08-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.